Studies on the cellular uptake of substance P and lysine-rich, KLA-derived model peptides

Journal of Molecular Recognition

Volumn 18, Issue 1, 2005, Pages 50-59

  Oehlke, Johannes ^a   Lorenz, Dorothea ^a   Wiesner, Burkhard ^a   Bienert, Michael ^a  

^a LEIBNIZ INSTITUT FÜR MOLEKULARE PHARMAKOLOGIE   (Germany)

Author keywords

Cell penetrating peptides; Cellular uptake; Confocal laser scanning microscopy; Endocytosis; Mast cell degranulation; Model peptides; Oligonucleotide; Peptide nucleic acid; Peptide lipid membrane interaction; Substance P

Indexed keywords

LYSINE; PEPTIDE; SUBSTANCE P;

ANIMAL; CELL MEMBRANE; CELL NUCLEUS; CHEMISTRY; CYTOSOL; DEGRANULATION; MAST CELL; METABOLISM; PHYSIOLOGY; PROTEIN TRANSPORT; RAT; REVIEW;

ANIMALS; CELL DEGRANULATION; CELL MEMBRANE; CELL NUCLEUS; CYTOSOL; LYSINE; MAST CELLS; PEPTIDES; PROTEIN TRANSPORT; RATS; SUBSTANCE P;

EID: 11244335404     PISSN: 09523499     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmr.691     Document Type: Review

References (136)

1. Ashkenazi A, Dixit VM. 1998. Death receptors: signaling and modulation. Science 281: 1305-1308.
2. Ballatori N, Truong AT. 1995. Multiple canalicular transport mechanisms for glutathione S-conjugates - transport on both ATP-dependent and voltage-dependent carriers. J. Biol. Chem. 270: 3594-3601.
3. Beck GF, Irwin WJ, Nicklin PL, Akhtar S. 1996. Interactions of phosphodiester and phosphorothioate oligonucleotides with intestinal epithelial Caco-2 cells. Pharm. Res. 13: 1028-1037.
4. 2 of G protein activation in rat brain preparations and of chronotropic effect on rat cardiomyocytes evoked by nociceptin orphanin FQ. Brit. J. Pharmac. 126: 555-558.
5. Binder H, Lindblom G. 2003. Charge-dependent translocation of the Trojan peptide penetratin across lipid membranes. Biophys. J. 85: 982-995.
6. Bonnet D, Thiam K, Loing E, Melnyk O, Gras-Masse H. 2001. Synthesis by chemoselective ligation and biological evaluation of novel cell-permeable PKC-zeta pseudosubstrate lipopeptides. J. Med. Chem. 44: 468-471.
7. Braasch DA, Corey DR. 2002. Novel antisense and peptide nucleic acid strategies for controlling gene expression. Biochemistry 41: 4503-4510.
8. Braun K, Peschke P, Pipkorn R, Lampel S, Wachsmuth M, Waldeck W, Friedrich E, Debus J. 2002. A biological transporter for the delivery of peptide nucleic acids (PNAs) to the nuclear compartment of living cells. J. Mol. Biol. 318: 237-243.
9. Burton PS, Conradi RA, Hilgers AR, Ho NFH, Maggiora LL. 1992. The relationship between peptide structure and transport across epithelial cell monolayers. J. Controlled Release 19: 87-98.
10. 2C receptors in choroid plexus epithelial cells. J. Biol. Chem. 275: 7021-7029.
11. Cole SPC, Bhardwaj G, Gerlach JH, Mackie JE, Grant CE, Almquist KC, Stewart AJ, Kurz EU, Duncan AMV, Deeley RG. 1992. Overexpression of a transporter gene in a multidrug-resistant human lung-cancer cell line. Science 258: 1650-1654.
12. Cross LJM, Ennis M, Krause E, Dathe M, Lorenz D, Krause G, Beyermann M, Bienert M. 1995. Influence of alpha-helicity, amphipathicity and D-amino acid incorporation on the peptide-induced mast cell activation. Eur. J. Pharmac. 291: 291-300.
13. Dathe M, Wieprecht T. 1999. Structural features of helical antimicrobial peptides: their potential to modulate activity on model membranes and biological cells. Biochim. Biophys. Acta 1462: 71-87.
14. Dathe M, Wieprecht T, Nikolenko H, Handel L, Maloy WL, MacDonald DL, Beyermann M, Bienert M. 1997. Hydrophobicity, hydrophobic moment and angle subtended by charged residues modulate antibacterial and haemolytic activity of amphipathic helical peptides. FEBS Lett. 403: 208-212.
15. Derossi D, Joliot AH, Chassaing G, Prochiantz A. 1994. The 3rd helix of the antennapedia homeodomain translocates through biological membranes. J. Biol. Chem. 269: 10444-10450.
16. Derossi D, Calvet S, Trembleau A, Brunissen A, Chassaing G, Prochiantz A. 1996. Cell internalization of the third helix of the Antennapedia homeodomain is receptor-independent. J. Biol. Chem. 271: 18188-18193.
17. Drin G, Mazel M, Clair P, Mathieu D, Kaczorek M, Temsamani J. 2001. Physico-chemical requirements for cellular uptake of pAntp peptide - role of lipid-binding affinity. Eur. J. Biochem. 268: 1304-1314.
18. Ehrlich A, Heyne H-U, Beyermann M, Dathe M, Bienert M. 2001. Influence of backbone modification on the hybridization potency of peptide nucleic acids (PNAs). In Peptides 2000, Martinez J, Fehrentz J-A (eds). Editions EDK: Paris; 977-978.
19. Eichholtz T, Debont DBA, Dewidt J, Liskamp RMJ, Ploegh HL. 1993. A myristoylated pseudosubstrate peptide, a novel protein-kinase-C inhibitor. J. Biol. Chem. 268: 1982-1986.
20. Emadikhiav B, Mousli M, Bronner C, Landry Y. 1995. Human and rat cutaneous mast-cells - involvement of a G-protein in the response to peptidergic stimuli. Eur. J. Pharmac. 272: 97-102.
21. Epa WR, Rong P, Bartlett PF, Coulson EJ, Barrett GL. 1998. Enhanced downregulation of the p75 nerve growth factor receptor by cholesteryl and bis-cholesteryl antisense oligonucleotides. Antisense Nucl. Acid Drug Dev. 8: 489-498.
22. Eriksson M, Nielsen PE, Good L. 2002. Cell permeabilization and uptake of antisense peptide-peptide nucleic acid (PNA) into Escherichia coli. J. Biol. Chem. 277: 7144-7147.
23. Faulstich H, Wieland T. 1996. New aspects of amanitin and phalloidin poisoning. Adv. Exp. Med. Biol. 391: 309.
24. Ferry X, Brehin S, Kamel R, Landry Y. 2002. G protein-dependent activation of mast cell by peptides and basic secretagogues. Peptides 23: 1507-1515.
25. Fischer R, Waizenegger T, Kohler K, Brock R. 2002. A quantitative validation of fluorophore-labelled cell-permeable peptide conjugates: fluorophore and cargo dependence of import. Biochim. Biophys. Acta 1564: 365-374.
26. Freulon I, Roche AC, Monsigny M, Mayer R. 2001. Delivery of oligonucleotides into mammalian cells by anionic peptides: comparison between monomeric and dimeric peptides. Biochem. J. 354: 671-679.
27. Fridkin G, Gilon T, Loyter A, Gilon C. 2001. Systematic solid-phase synthesis of linear pseudooligolysines containing multiple adjacent CH2NH amide bond surrogates: potential agents for gene delivery. J. Pept. Res. 58: 36-44.
28. Futaki S, Suzuki T, Ohashi W, Yagami T, Tanaka S, Ueda K, Sugiura Y. 2001. Arginine-rich peptides - an abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery. J. Biol. Chem. 276: 5836-5840.
29. Gait MJ. 2003. Peptide-mediated cellular delivery of antisense oligonucleotides and their analogues. Cell Mol. Life Sci. 60: 844-853.
30. Gariepy J, Kawamura K. 2001. Vectorial delivery of macromolecules into cells using peptide-based vehicles. Trends Biotechnol. 19: 21-28.
31. Good L, Awasthi SK, Dryselius R, Larsson O, Nielsen PE. 2001. Bactericidal antisense effects of peptide-PNA conjugates. Nat. Biotechnol. 19: 360-364.
32. Green I, Christison R, Voyce CJ, Bundell KR, Lindsay MA. 2003. Protein transduction domains: are they delivering? Trends Pharmac. Sci. 24: 213-215.
33. Grundemar L, Hakanson R. 1991. Neuropeptide-Y, peptide-YY and C-terminal fragments release histamine from rat peritoneal mast-cells. Br. J. Pharmac. 104: 776-778.
34. Guillot FL, Audus KL, Raub TJ. 1990. Fluid-phase endocytosis by primary cultures of bovine brain microvessel endothelial-cell monolayers. Microvasc. Res. 39: 1-14.
35. Haaima G, Rasmussen H, Schmidt G, Jensen DK, Kastrup JS, Stafshede PW, Norden B, Buchardt O, Nielsen PE. 1999. Peptide nucleic acids (PNA) derived from N-(N-methylaminoethyl)glycine. Synthesis, hybridization and structural properties. New J. Chem. 23: 833-840.
36. Hällbrink M, Floren A, Elmquist A, Pooga M, Bartfai T, Langel U. 2001. Cargo delivery kinetics of cell-penetrating peptides. Biochim. Biophys. Acta 1515: 101-109.
37. Hansen SH, Sandvig K, Vendeurs B. 1993. Clathrin and Ha2 adapters - effects of potassium-depletion, hypertonic medium, and cytosol acidification. J. Cell. Biol. 121: 61-72.
38. Hawiger J. 1997. Cellular import of functional peptides to block intracellular signaling. Curr. Opin. Immunol. 9: 189-194.
39. Hinterding K, Alonso-Diaz D, Waldmann H. 1998. Organic synthesis and biological signal transduction. Angew. Chem. Int. Ed. Engl. 37: 688-749.
40. Hughes MD, Hussain M, Nawaz Q, Sayyed P, Akhtar S. 2001. The cellular delivery of antisense oligonucleotides and ribozymes. Drug Discov. Today 6: 303-315.
41. Juliano RL, Alahari S, Yoo H, Kole R, Cho M. 1999. Antisense pharmacodynamics: critical issues in the transport and delivery of antisense oligonucleotides. Pharm. Res. 16: 494-502.
42. Kamata H, Yagisawa H, Takahashi S, Hirata H. 1994. Amphiphilic peptides enhance the efficiency of liposome-mediated DNA transfection. Nucl. Acids Res. 22: 536-537.
43. Kerth A, Erbe A, Dathe M, Blume A. 2004. Infrared reflection absorption spectroscopy of amphipathic model peptides at the air/water interface. Biophys. J. 86: 3750-3758.
44. Kichler A, Leborgne C, Marz J, Danos O, Bechinger B. 2003. Histidine-rich amphipathic peptide antibiotics promote efficient delivery of DNA into mammalian cells. Proc. Natl. Acad. Sci. USA 100: 1564-1568.
45. Kole HK, Liotta AS, Kole S, Roth J, MontroseRafizadeh C, Bernier M. 1996. A synthetic peptide derived from a COOH-terminal domain of the insulin receptor specifically enhances insulin receptor signaling. J. Biol. Chem. 271: 31619-31626.
46. Koller E, Gaarde WA, Monia BP. 2000. Elucidating cell signaling mechanisms using antisense technology. Trends Pharmac. Sci. 21: 142-148.
47. Koppelhus U, Nielsen PE. 2003. Cellular delivery of peptide nucleic acid (PNA). Adv. Drug Deliv. Rev. 55: 267-280.
48. Koppelhus U, Awasthi SK, Zachar V, Holst HU, Ebbesen P, Nielsen PE. 2002. Cell-dependent differential cellular uptake of PNA, peptides, and PNA-peptide conjugates. Antisense Nucl. Acid Drug Dev. 12: 51-63.
49. Krause E, Beyermann M, Dathe M, Rothemund S, Bienert M. 1995. Location of an amphipathic alpha-helix in peptides using reversed-phase HPLC retention behavior of D-amino acid analogs. Anal. Chem. 67: 252-258.
50. Krause E, Beyermann M, Fabian H, Dathe M, Rothemund S, Bienert M. 1996. Conformation of of a water-soluble beta-sheet model peptide - a circular dichroism and Fourier-transform infrared spectroscopic study of double D-amino acid replacements. Intern. J. Peptide Protein Res. 48: 559-568.
51. Krieg AM, Tonkinson J, Matson S, Zhao QY, Saxon M, Zhang LM, Bhanja U, Yakubov L, Stein CA. 1993. Modification of antisense phosphodiester oligodeoxynucleotides by a 5′ cholesteryl moiety increases cellular-association and improves efficacy. Proc. Nat. Acad. Sci. USA 90: 1048-1052.
52. de Kroon AI, Vogt B, van't Hof R, de Kruijff B, de Gier J. 1991. Ion gradient-induced membrane translocation of model peptides. Biophys. J. 60: 525-537.
53. Landry Y, Bronner C, Mousli M, Fischer T, Valle A. 1992. The activation of mast-cells - molecular targets and transducing processes for antigenic and nonantigenic stimuli. B. I. Pasteur. 90: 83-98.
54. Lebleu B. 1996. Delivering information-rich drugs - prospects and challenges. Trends Biotechnol. 14: 109-110.
55. Leifert JA, Whitton JL. 2003. Translocatory proteins' and 'Protein transduction domains': a critical analysis of their biological effects and the underlying mechanisms. Mol. Ther. 8: 13-20.
56. Letsinger RL, Zhang GG, Sun DK, Ikeuchi T, Sarin PS. 1989. Cholesteryl-conjugated oligonucleotides - synthesis, properties, and activity as inhibitors of replication of human immunodeficiency virus in cell-culture. Proc. Natl. Acad. Sci. USA. 86: 6553-6556.
57. Levitzki A. 1996. Targeting signal transduction for disease therapy. Curr. Opin. Cell Biol. 8: 239-244.
58. Lindgren M, Hällbrink M, Prochiantz A, Langel U. 2000. Cell-penetrating peptides. Trends Pharmac. Sci. 21: 99-103.
59. Lippincott-Schwartz J, Yuan LC, Bonifacino JS, Klausner RD. 1989. Rapid redistribution of golgi proteins into the ER in cells treated with brefeldin-A - evidence for membrane cycling from golgi to ER. Cell 56: 801-813.
60. Lorenz D, Wiesner B, Zipper J, Winkler A, Krause E, Beyermann M, Lindau M, Bienert M. 1998. Mechanism of peptide-induced mast cell degranulation - translocation and patch-clamp studies. J. Gen. Physiol. 112: 577-591.
61. Lundberg M, Johansson M. 2001. Is VP22 nuclear homing an artifact? Nat. Biotechnol. 19: 713.
62. Lundberg P, Langel U. 2003. A brief introduction to cell-penetrating peptides. J. Mol. Recognit. 16: 227-233.
63. Maduke M, Roise D. 1993. Import of a mitochondrial presequence into protein-free phospholipid-vesicles. Science 260: 364-367.
64. Mai JC, Shen H, Watkins SC, Cheng T, Robbins PD. 2002. Efficiency of protein transduction is cell type-dependent and is enhanced by dextrane sulfate. J. Biol. Chem. 277: 30208-30218.
65. Matsuzaki K, Murase O, Miyajima K. 1995. Kinetics of pore formation by an antimicrobial peptide, magainin-2, in phospholipid-bilayers. Biochemistry 34: 12553-12559.
66. Matsuzaki K, Yoneyama S, Murase O, Miyajima K. 1996. Transbilayer transport of ions and lipids coupled with mastoparan X translocation. Biochemistry 35: 8450-8456.
67. Mayfield LD, Corey DR. 1999. Automated synthesis of peptide nucleic acids and peptide nucleic acid peptide conjugates. Anal. Biochem. 268: 401-404.
68. Mellman I. 1996. Endocytosis and molecular sorting. A. Rev. Cell Dev. Biol. 12: 575-625.
69. Mitchell DJ, Kim DT, Steinman L, Fathman CG, Rothbard JB. 2000. Polyarginine enters cells more efficiently than other polycationic homopolymers. J. Pept. Res. 56: 318-325.
70. Morris MC, Chaloin L, Heitz F, Divita G. 2000. Translocating peptides and proteins and their use for gene delivery. Curr. Opin. Biotechnol. 11: 461-466.
71. Morris MC, Depollier J, Mery J, Heitz F, Divita G. 2001. A peptide carrier for the delivery of biologically active proteins into mammalian cells. Nat. Biotechnol. 19: 1173-1176.
72. Mousli M, Bronner C, Bueb JL, Tschirhart E, Gies JP, Landry Y. 1989. Activation of rat peritoneal mast-cells by substance P and mastoparan. J. Pharmac. Exp. Ther. 250: 329-335.
73. Mousli M, Bronner C, Landry Y, Bockaert J, Rouot B. 1990a. Direct activation of GTP-binding regulatory proteins (G-Proteins) by substance P and compound 48/80. FEBS Lett. 259: 260-262.
74. Mousli M, Bueb JL, Bronner C, Rouot B, Landry Y. 1990b. G-Protein activation - a receptor-independent mode of action for cationic amphiphilic neuropeptides and venom peptides. Trends Pharmac. Sci. 11: 358-362.
75. Mousli M, Hugli TE, Landry Y, Bronner C. 1994. Peptidergic pathway in human skin and rat peritoneal mast-cell activation. Immunopharmacology 27: 1-11.
76. Niidome T, Ohmori N, Ichinose A, Wada A, Mihara H, Hirayama T, Aoyagi H. 1997. Binding of cationic alpha-helical peptides to plasmid DNA and their gene transfer abilities into cells. J. Biol. Chem. 272: 15307-15312.
77. Niidome T, Urakawa M, Takaji K, Matsuo Y, Ohmori N, Wada A, Hirayama T, Aoyagi H. 1999. Influence of lipophilic groups in cationic alpha-helical peptides on their abilities to bind with DNA and deliver genes into cells. J. Pept. Res. 54: 361-367.
78. Oehlke J, Savoly B, Blasig IE. 1994. Utilization of endothelial cell monolayers of low tightness for estiamation of transcellular transport characteristics of hydrophilic compounds. Eur. J. Pharm. Sci. 2: 365.
79. Oehlke J, Krause E, Wiesner B, Beyermann M, Bienert M. 1997. Extensive cellular-uptake into endothelial cells of an amphipathic beta-sheet forming peptide. FEBS Lett. 415: 196-199.
80. Oehlke J, Scheller A, Wiesner B, Krause E, Beyermann M, Klauschenz E, Melzig M, Bienert M. 1998. Cellular uptake of an alpha-helical amphipathic model peptide with the potential to deliver polar compounds into the cell interior nonendocytically. Biochim. Biophys. Acta 1414: 127-139.
81. Oehlke J, Scheller A, Birth P, Wiesner B, Beyermann B, Faulstich H, Bienert M. 2000. Structural requirements for the cellular uptake of peptides. In The Eighgt Akabori Conference, Shioiri T (ed.). Akabori Conference Association; 96-100.
82. Oehlke J, Wiesner B, Bienert M. 2002. Model amphipathic peptides. In Handbook of Cell-Penetrating Peptides, Langel Ü (ed.). CRC Press LLC: Boca Raton, FL; 71-92.
83. Oehlke J, Birth P, Klauschenz E, Wiesner B, Beyermann M, Oksche A, Bienert M. 2002. Cellular uptake of antisense oligonucleotides after complexing or conjugation with cell-penetrating model peptides. Eur. J. Biochem. 269: 4025-4032.
84. O'Flynn NM, Helme RD, Watkins DJ, Burcher E. 1989. Autoradiographic localization of substance P binding sites in rat footpad skin. Neurosci. Lett. 106: 43-48.
85. Ohkuma S, Poole B. 1978. Fluorescence probe measurement of intralysosomal pH in living cells and perturbation of pH by various agents. Proc. Natl. Acad. Sci. USA 75: 3327-3331.
86. Ohmori N, Niidome T, Wada A, Hirayama T, Hatakeyama T, Aoyagi H. 1997. The enhancing effect of anionic alpha-helical peptide on cationic peptide-mediating transfection systems. Biochem. Biophys. Res. Commun. 235: 726-729.
87. Paton WDM. 1951. Compound 48 80 - a potent histamine liberator. Br. J. Pharm. Chemother. 6: 499-508.
88. Pichon C, Freulon I, Midoux P, Mayer R, Monsigny M, Roche AC. 1997. Cytosolic and nuclear delivery of oligonucleotides mediated by an amphiphilic anionic peptide. Antisense Nucl. Acid Drug Dev. 7: 335-343.
89. Pichon C, Roufai MB, Monsigny M, Midoux P. 2000. Histidylated oligolysines increase the transmembrane passage and the biological activity of antisense oligonucleotides. Nucl. Acids Res. 28: 504-512.
90. Pooga M, Hällbrink M, Zorko M, Langel Ü. 1998. Cell penetration by transportan. FASEB J. 12: 67-77.
91. Pooga M, Kut C, Kihlmark M, Hällbrink M, Fernaeus S, Raid R, Land T, Hallberg E, Bartfai T, Langel Ü. 2001a. Cellular translocation of proteins by transportan. FASEB J. 15.
92. Pooga M, Land T, Bartfai T, Langel Ü. 2001 b. PNA oligomers as tools for specific modulation of gene expression. Biomol. Eng. 17: 183-192.
93. Prochiantz A. 1996. Getting hydrophilic compounds into cells: Lessons from homeopeptides. Curr. Opin. Neurobiol. 6: 629-634.
94. Purcell WM, Doyle KM, Westgate C, Atterwill CK. 1996. Characterisation of a functional polyamine site on rat mast cells: Association with a NMDA receptor macrocomplex. J. Neuroimmunol. 65: 49-53.
95. Repke H, Bienert M. 1987. Mast cell activation - a receptor-independent mode of substance P action. FEBS Lett. 221: 236-240.
96. 3 from rat peritoneal mast cells. J. Pharmac. Exp. Ther. 243: 317-321.
97. Richard JP, Melikov K, Vives E, Ramos C, Verbeure B, Gait MJ, Chernomordik LV, Lebleu B. 2003. Cell-penetrating peptides - a reevaluation of the mechanism of cellular uptake. J. Biol. Chem. 278: 585-590.
98. Rojas M, Donahue JP, Tan ZJ, Lin YZ. 1998. Genetic engineering of proteins with cell membrane permeability. Nat. Biotechnol. 16: 370-375.
99. Rothbard JB, Kreider E, Vandeusen CL, Wright L, Wylie BL, Wender PA. 2002. Arginine-rich molecular transporters for drug delivery: role of backbone spacing in cellular uptake. J. Med. Chem. 45: 3612-3618.
100. Rothemund S, Krause E, Beyermann M, Dathe M, Engelhardt H, Bienert M. 1995. Recognition of alpha-helical peptide structures using high performance liquid-chromatographic retention data for D-amino acid analogs - influence of peptide amphipathicity and of stationary phase hydrophobicity. J. Chromatogr. A 689: 219-226.
101. Rothemund S, Krause E, Beyermann M, Dathe M, Bienert M, Hodges RS, Sykes BD, Sönnichsen FD. 1996. Peptide destabilization by two adjacent D-amino acids in single-stranded amphipathic alpha-helices. Pept. Res. 9: 79-87.
102. Rueping M, Mahajan Y, Sauer M, Seebach D. 2002. Cellular uptake studies with beta-peptides. Chembiochemistry 3: 257-259.
103. Sayama S, Iozzo RV, Lazarus GS, Schechter NM. 1987. Human skin chymotrypsin-like proteinase chymase - subcellular localization to mast cell granules and interaction with heparin and other glycosaminoglycans. J. Biol. Chem. 262: 6808-6815.
104. Scheller A, Oehlke J, Wiesner B, Dathe M, Krause E, Beyermann M, Melzig M, Bienert M. 1999. Structural requirements for cellular uptake of alpha-helical amphipathic peptides. J. Pept. Sci. 5: 185-194.
105. Scheller A, Wiesner B, Melzig M, Bienert M, Oehlke J. 2000. Evidence for an amphipathicity independent cellular uptake of amphipathic cell-penetrating peptides. Eur. J. Biochem. 267: 6043-6049.
106. Scheller A, Melzig M, Oehlke J. 2001. Induction of caspase-8 in human cells by the extracellular administration of peptides containing a C-terminal SLV sequence. Lett. Pept. Sci. 8: 29-34.
107. Schwarze SR, Dowdy SF. 2000. In vivo protein transduction: intracellular delivery of biologically active proteins, compounds and DNA. Trends Pharmac. Sci. 21: 45-48.
108. Shen WC, Ryser HJP. 1978. Conjugation of poly-L-lysine to albumin and horseradish peroxidase - novel method of enhancing cellular uptake of proteins. Proc. Natl. Acad. Sci. USA 75: 1872-1876.
109. Shen WC, Wan JS, Ekrami H. 1992. Enhancement of polypeptide and protein-absorption by macromolecular carriers via endocytosis and transcytosis. Adv. Drug Deliv. Rev. 8: 93-113.
110. Simeoni F, Morris MC, Heitz F, Divita G. 2003. Insight into the mechanism of the peptide-based gene delivery system MPG: implications for delivery of siRNA into mammalian cells. Nucl. Acids Res. 31: 2717-2724.
111. Souroujon MC, Mochly-Rosen D. 1998. Peptide modulators of protein-protein interactions in intracellular signaling. Nat. Biotechnol. 16: 919-924.
112. Steiner V, Schar M, Bornsen KO, Mutter M. 1991. Retention behavior of a template-assembled synthetic protein and its amphiphilic building blocks on reversed-phase columns. J. Chromatogr. 586: 43-50.
113. Takeshima K, Chikushi A, Lee KK, Yonehara S, Matsuzaki K. 2003. Translocation of analogues of the antimicrobial peptides magainin and buforin across human cell membranes. J. Biol. Chem. 278: 1310-1315.
114. Terrone D, Sang SLW, Roudaia L, Silvius JR. 2003. Penetratin and related cell-penetrating cationic peptides can translocate across lipid bilayers in the presence of a transbilayer potential. Biochemistry 42: 13787-13799.
115. Thiam K, Loing E, Delanoye A, Diesis E, Gras-Masse H, Auriault C, Verwaerde C. 1998. Unrestricted agonist activity on murine and human cells of a lipopeptide derived from IFN-gamma. Biochem. Biophys. Res. Commun. 253: 639-647.
116. Thierry AR, Vives E, Richard JP, Prevot P, Martinand-Mari C, Robbins I, Lebleu B. 2003. Cellular uptake and intracellular fate of antisense oligonucleotides. Curr. Opin. Mol. Ther. 5: 133-138.
117. Thomas RM, Thomas T, Wada M, Sigal LH, Shirahata A, Thomas TJ. 1999. Facilitation of the cellular uptake of a tripler-forming oligonucleotide by novel polyamine analogues: Structure-activity relationships. Biochemistry 38: 13328-13337.
118. Thoren PEG, Persson D, Karlsson M, Norden B. 2000. The Antennapedia peptide penetratin translocates across lipid bilayers - the first direct observation. FEBS Lett. 482: 265-268.
119. Thoren PEG, Persson D, Isakson P, Goksor M, Onfelt A, Norden B. 2003. Uptake of analogs of penetratin, Tat(48-60) and oligoarginine in live cells. Biochem. Biophys. Res. Commun. 307: 100-107.
120. Tung CH, Stein S. 2000. Preparation and applications of peptide-oligonucleotide conjugates. Bioconjug. Chem. 11: 605-618.
121. Umezawa N, Gelman MA, Haigis MC, Raines RT, Gellman SH. 2002. Translocation of a beta-peptide across cell membranes. J. Am. Chem. Soc. 124: 368-369.
122. Vaara M, Porro M. 1996. Group of peptides that act synergistically with hydrophobic antibiotics against Gram-negative enteric bacteria. Antimicrob. Agents Chemother. 40: 1801-1805.
123. Veach RA, Liu DY, Yao S, Chen YL, Liu XY, Downs S, Hawinger J. 2004. Receptor/transporter-independent targeting of functional peptides across the plasma membrane. J. Biol. Chem. 279: 11425-11431.
124. Vijayaraghavan S, Goueli SA, Davey MP, Carr DW. 1997. Protein kinase A-anchoring inhibitor peptides arrest mammalian sperm motility. J. Biol. Chem. 272: 4747-4752.
125. Vives E, Brodin P, Lebleu B. 1997. A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J. Biol. Chem. 272: 16010-16017.
126. Vives E, Dell'Aquila C, Bologna JC, Morvan F, Rayner B, Imbach JL. 1999. Lipophilic pro-oligonucleotides are rapidly and efficiently internalized in HeLa cells. Nucl. Acids Res. 27: 4071-4076.
127. Wender PA, Mitchell DJ, Pattabiraman K, Pelkey ET, Steinman L, Rothbard JB. 2000. The design, synthesis, and evaluation of molecules that enable or enhance ellular uptake: peptoid molecular transporters. Proc. Nat. Acad. Sci. USA 97: 13003-13008.
128. Wender PA, Rothbard JB, Jessop TC, Kreider EL, Wylie BL. 2002. Oligocarbamate molecular transporters: design, synthesis, and biological evaluation of a new class of transporters for drug delivery. J. Am. Chem. Soc. 124: 13382-13383.
129. Wieland T. 1968. Poisonous principles of mushrooms of genus amanita - 4-carbon amines acting on central nervous system and cell-destroying cyclic peptides are produced. Science 159: 946.
130. Wieprecht T, Rothemund S, Bienert M, Krause E. 2001. Role of helix formation for the retention of peptides in reversed-phase high-performance liquid chromatography. J. Chromatogr. A 912: 1-12.
131. Wieprecht T, Beyermann M, Seelig J. 2002. Thermodynamics of the coil-alpha-helix transition of amphipathic peptides in a membrane environment. The role of vesicle curvature. Biophys. Chem. 96: 191-201.
132. Wiesner B, Lorenz D, Krause E, Beyermann M, Bienert M. 2002. Measurement of intracellular fluorescence in the presence of a strong extracellular fluorescence using confoal laser scanning microscopy. LAMSO 3: 1-17.
133. Wright LR, Rothbard JB, Wender PA. 2003. Guanidinium rich peptide transporters and drug delivery. Curr. Protein Pept. Sci. 4: 105-124.
134. Wyman TB, Nicol F, Zelphati O, Scaria PV, Plank C, Szoka FC. 1997. Design, synthesis, and characterization of a cationic peptide that binds to nucleic acids and permeabilizes bilayers. Biochemistry 36: 3008-3017.
135. Yanagisawa J, Takahashi M, Kanki H, Yano Yanagisawa H, Tazunoki T, Sawa E, Nishitoba T, Kamishohara M, Kobayashi E, Kataoka S, Sato T. 1997. The molecular interaction of Fas and FAP-1 - a tripeptide blocker of human Fas interaction with FAP-1 promotes Fas-induced apoptosis. J. Biol. Chem. 272: 8539-8545.
136. Ziegler Ȧ, Blatter XL, Seelig A, Seelig J. 2003. Protein transduction domains of HIV-1 and SIV TAT interact with charged lipid vesicles. Binding mechanism and thermodynamic analysis. Biochemistry 42: 9185-9194.